166 related articles for article (PubMed ID: 10831163)
1. Effects of growth hormone treatment on very-low density lipoprotein apolipoprotein B100 turnover in adult hypopituitarism.
Chrisoulidou A; Kousta E; Venkatesan S; Gray R; Bannister PA; Gallagher JJ; Lawrence N; Johnston DG
Metabolism; 2000 May; 49(5):563-6. PubMed ID: 10831163
[TBL] [Abstract][Full Text] [Related]
2. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
[TBL] [Abstract][Full Text] [Related]
3. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study.
Christ ER; Cummings MH; Albany E; Umpleby AM; Lumb PJ; Wierzbicki AS; Naoumova RP; Boroujerdi MA; Sönksen PH; Russell-Jones DL
J Clin Endocrinol Metab; 1999 Jan; 84(1):307-16. PubMed ID: 9920100
[TBL] [Abstract][Full Text] [Related]
4. Very-low-density lipoprotein apolipoprotein B100 kinetics in adult hypopituitarism.
Chrisoulidou A; Kousta E; Venkatesan S; Gray R; Bannister PA; Gallagher JJ; Johnston DG
Metabolism; 1999 Aug; 48(8):1057-62. PubMed ID: 10459574
[TBL] [Abstract][Full Text] [Related]
5. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
6. Hypopituitarsim is associated with triglyceride enrichment of very low-density lipoprotein.
Kearney T; Navas de Gallegos C; Chrisoulidou A; Gray R; Bannister P; Venkatesan S; Johnston DG
J Clin Endocrinol Metab; 2001 Aug; 86(8):3900-6. PubMed ID: 11502830
[TBL] [Abstract][Full Text] [Related]
7. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
O'Neal DN; Hew FL; Best JD; Alford F
Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
[TBL] [Abstract][Full Text] [Related]
8. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
[TBL] [Abstract][Full Text] [Related]
9. Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: a randomised controlled trial.
Giannoulis MG; Jackson N; Shojaee-Moradie F; Sonksen PH; Martin FC; Umpleby AM
Growth Horm IGF Res; 2006; 16(5-6):308-17. PubMed ID: 17029996
[TBL] [Abstract][Full Text] [Related]
10. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope study.
Christ ER; Cummings MH; Stolinski M; Jackson N; Lumb PJ; Wierzbicki AS; Sönksen PH; Russell-Jones DL; Umpleby AM
Eur J Endocrinol; 2006 Mar; 154(3):459-66. PubMed ID: 16498060
[TBL] [Abstract][Full Text] [Related]
12. Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia.
Tatò F; Keller C; Wolfram G
Clin Investig; 1993 Apr; 71(4):314-8. PubMed ID: 8471818
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
[TBL] [Abstract][Full Text] [Related]
14. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
[TBL] [Abstract][Full Text] [Related]
15. Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects.
Watts GF; Naoumova R; Cummings MH; Umpleby AM; Slavin BM; Sönksen PH; Thompson GR
Metabolism; 1995 Aug; 44(8):1052-7. PubMed ID: 7637647
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of Troglitazone in patients with diet-controlled type 2 diabetes.
Robinson AC; Jeffs JA; Gray RG; Bannister PA; Mather H; Gallagher JJ; Robinson S; Nattrass M; Venkatesan S; Halliday D; Johnston DG
Eur J Clin Invest; 2004 Jan; 34(1):29-36. PubMed ID: 14984435
[TBL] [Abstract][Full Text] [Related]
17. Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus.
Christ ER; Carroll PV; Albany E; Umpleby AM; Lumb PJ; Wierzbicki AS; Sönksen PH; Russell-Jones DL
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1154-62. PubMed ID: 11934682
[TBL] [Abstract][Full Text] [Related]
18. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.
al-Shoumer KA; Gray R; Anyaoku V; Hughes C; Beshyah S; Richmond W; Johnston DG
Clin Endocrinol (Oxf); 1998 Jun; 48(6):795-802. PubMed ID: 9713570
[TBL] [Abstract][Full Text] [Related]
19. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
20. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
